spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Detjen, K. M.
Right arrow Articles by Rosewicz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Detjen, K. M.
Right arrow Articles by Rosewicz, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Cell Science, Vol 113, Issue 17 3025-3035, Copyright © 2000 by Company of Biologists

JOURNAL ARTICLES

Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest

KM Detjen, FH Brembeck, M Welzel, A Kaiser, H Haller, B Wiedenmann and S Rosewicz
Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Universitatsklinikum Charite, Campus Virchow Klinikum, Augustenburger Platz 1, Germany.

We have analyzed human pancreatic cancer cells to explore the growth regulatory function of protein kinase C (PKC)alpha. PKCalpha subcellular redistribution, activation kinetics and downregulation were examined in detail and correlated to immediate and delayed effects on cell-cycle regulatory pathways. TPA treatment resulted in transient PKC(&agr;) activation accompanied by translocation of the enzyme into membrane and nuclear compartments, and was followed by subsequent downregulation. TPA-induced inhibition of DNA synthesis was prevented by a PKC-antagonist and was reproduced by microinjection of recombinant PKCalpha, indicating that activation of this isoenzyme was required and sufficient for growth inhibitory effects. PKC(&agr;) activation arrested cells in the G(1) phase of the cell cycle as a consequence of selective inhibition of cyclin dependent kinase (CDK)2 activity with concomitant hypophosphorylation of Rb. The inhibition of CDK2 activity resulted from induction of p21(cip1) cyclin-dependent kinase inhibitors. Levels of p21(cip1) remained elevated and CDK2 activity repressed in spite of PKCalpha downregulation, indicating that downstream effectors of PKCalpha are the primary determinants for the duration of PKC-mediated growth inhibition. The PKCalpha-induced block in cell proliferation persisted even though cells were kept in the presence of growth factors, suggesting that induction of PKCalpha results in a permanent withdrawal of pancreatic cancer cells from the cell cycle.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
H. J. Lee, Y. Ji, S. Paul, H. Maehr, M. Uskokovic, and N. Suh
Activation of Bone Morphogenetic Protein Signaling by a Gemini Vitamin D3 Analogue Is Mediated by Ras/Protein Kinase C{alpha}
Cancer Res., December 15, 2007; 67(24): 11840 - 11847.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. A. Hizli, A. R. Black, M. A. Pysz, and J. D. Black
Protein Kinase C {alpha} Signaling Inhibits Cyclin D1 Translation in Intestinal Epithelial Cells
J. Biol. Chem., May 26, 2006; 281(21): 14596 - 14603.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
G. E. Avila, X. Zheng, X. X. Cui, A. D. Ryan, A. Hansson, J. Suh, A. B. Rabson, R. L. Chang, W. J. Shih, Y. Lin, et al.
Inhibitory Effects of 12-O-Tetradecanoylphorbol-13-acetate Alone or in Combination with All-trans Retinoic Acid on the Growth of Cultured Human Pancreas Cancer Cells and Pancreas Tumor Xenografts in Immunodeficient Mice
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 170 - 187.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Zhu, Q. Dong, B. J. Tan, W. G. Lim, S. Zhou, and W. Duan
The PKC{alpha}-D294G Mutant Found in Pituitary and Thyroid Tumors Fails to Transduce Extracellular Signals
Cancer Res., June 1, 2005; 65(11): 4520 - 4524.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. Martinez, O. Vogler, J. Casas, F. Barcelo, R. Alemany, J. Prades, T. Nagy, C. Baamonde, P. G. Kasprzyk, S. Teres, et al.
Membrane Structure Modulation, Protein Kinase C{alpha} Activation, and Anticancer Activity of Minerval
Mol. Pharmacol., February 1, 2005; 67(2): 531 - 540.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Guha, J. A. Lunn, C. Santiskulvong, and E. Rozengurt
Neurotensin Stimulates Protein Kinase C-dependent Mitogenic Signaling in Human Pancreatic Carcinoma Cell Line PANC-1
Cancer Res., May 15, 2003; 63(10): 2379 - 2387.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Guha, O. Rey, and E. Rozengurt
Neurotensin Induces Protein Kinase C-dependent Protein Kinase D Activation and DNA Synthesis in Human Pancreatic Carcinoma Cell Line PANC-1
Cancer Res., March 1, 2002; 62(6): 1632 - 1640.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 2000